TRIAMINIC CHEST & NASAL CONGESTION OTC
Generic Name and Formulations:
Guaifenesin 50mg, phenylephrine HCl 2.5mg; per 5mL; liq; alcohol-free; tropical-flavored; contains sodium 3mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC CHEST & NASAL CONGESTION:
Cough and nasal congestion.
<4yrs: do not use. 4–6yrs: 5mL. 6–12yrs: 10mL. Repeat every 4 hours as needed; max 6 doses/24 hours.
Children <4yrs old. During or within 14 days of MAOIs.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Asthma. Lower respiratory disorders.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Expectorant + sympathomimetic.
Nervousness, dizziness, insomnia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Personal Health Information Found in Recycling
- Nightmares in Military Personnel Frequently Comorbid With Mental Health Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Addressing Racial Disparities in Bipolar Disorder Treatment
- Negative Symptoms Increase Cardiovascular Risk in Schizophrenia